| # | Side effect | Count |
|---|---|---|
| 0 | NEUTROPENIA | 4342 |
| 1 | FATIGUE | 3986 |
| 2 | NAUSEA | 3932 |
| 3 | MALIGNANT NEOPLASM PROGRESSION | 2842 |
| 4 | DEATH | 2554 |
| 5 | VOMITING | 2210 |
| 6 | DIARRHOEA | 2125 |
| 7 | WHITE BLOOD CELL COUNT DECREASED | 2076 |
| 8 | PAIN | 1940 |
| 9 | METASTASES TO BONE | 1825 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER | 205 | 0.6175 |
| 1 | ELLIPTOCYTOSIS | 45 | 0.5000 |
| 2 | ROULEAUX FORMATION | 25 | 0.4310 |
| 3 | EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL | 55 | 0.4135 |
| 4 | HER2 NEGATIVE BREAST CANCER | 21 | 0.4118 |
| 5 | CARBOHYDRATE ANTIGEN 15-3 INCREASED | 242 | 0.3180 |
| 6 | PIK3CA-ACTIVATED MUTATION | 89 | 0.2681 |
| 7 | TUMOUR MARKER DECREASED | 45 | 0.2514 |
| 8 | TUMOUR MARKER ABNORMAL | 57 | 0.1722 |
| 9 | METASTASES TO BREAST | 57 | 0.1717 |